Research and Development

Medical translation agency Conversis Medical has appointed Dr Mark Hooper as its global director. Hooper has worked in the pharma …

Boehringer Ingelheim has abandoned its hepatitis C (HCV) drug development programme as a dead loss after ‘re-evaluating’ its strategy. The …

Creative agency PAN has increased its team by hiring two new people in Minas Maroudas (pictured) who joins as senior …

The UK prime minister’s envoy on dementia has described progress on research into the neurodegenerative condition as ‘achingly slow’. Global …

AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …

The Medical Research Council (MRC) has launched the UK Dementias Research Platform (UKDP), a £16 million public-private partnership set up …

Bartlett Davis Communications has welcomed Dominique Pizzingrilli to the newly-created role of account manager. Pizzingrilli takes a wealth of healthcare …

The European regulator is to fast-track AbbVie’s oral, interferon-free treatment for adults with chronic genotype 1 (GT1) hepatitis C virus …

Amgen, Genentech, Pfizer, AstraZeneca and MedImmune – AstraZeneca’s global biologics R&D arm – have each put investigative treatments into a …

Amgen has poached David Meline from US multinational firm 3M to serve as an executive VP and chief financial officer. …

NICE needs to be reformed with its QALY formula heavily revised if it is to meet the challenges of 21st …

Pfizer has open a new 280,000 sq.ft. R&D hub in Cambridge, Massachusetts which also serves to bring together 1,000 of …

The Fishawack Group has appointed John Handley to fulfill the role of chairman for the UK medical comms specialists. Handley …

The European Medicines Agency is to formally agree its policy on the vexed issue of the publication of clinical trial …

UK drug development firm Avillion has appointed Lundbeck chief executive Ulf Wiinberg as the chairman of its board of directors. …